Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/29924| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Dimovski, Aleksandar | en_US |
| dc.contributor.author | Matevska, Nadica | en_US |
| dc.contributor.author | Eftimov, Aleksandar | en_US |
| dc.contributor.author | Kapedanovska Nestorovska, Aleksandra | en_US |
| dc.contributor.author | Angelovska Petrushevska, Natalija | en_US |
| dc.contributor.author | Angelovska, Biljana | en_US |
| dc.contributor.author | Jashar, Djengis | en_US |
| dc.contributor.author | Mitreski, Nenad | en_US |
| dc.contributor.author | Josifovski, Toni | en_US |
| dc.date.accessioned | 2024-04-08T06:28:19Z | - |
| dc.date.available | 2024-04-08T06:28:19Z | - |
| dc.date.issued | 2012 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/29924 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Oxford University Press on behalf of the European Society for Medical Oncology | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.title | MSI+ stage II/III colon cancer patients benefit from capecitabine adjuvant monotherapy | en_US |
| dc.type | Proceeding article | en_US |
| dc.relation.conference | ESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 27-30 June 2012 | en_US |
| item.grantfulltext | open | - |
| item.fulltext | With Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| Appears in Collections: | Faculty of Medicine: Conference papers Faculty of Medicine: Conference papers | |
Files in This Item:
| File | Опис | Size | Format | |
|---|---|---|---|---|
| 2012 ESMO 116.pdf | 59.57 kB | Adobe PDF | View/Open |
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.